Concepedia

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

Michael A. Pfaller, S. A. Messer, L. Boyken, R. J. Hollis, C. Rice, S. Tendolkar, Daniel J. Diekema

Diagnostic Microbiology and Infectious Disease · 2004 · 235 citations · 15 references

DOI

Concepts

References

15

Manual of Clinical Microbiology.

Annals of Internal Medicine · 1980 · 14.5K citations

, , +17

Manual of Clinical Microbiology

Jacob Blair, E H Lennette, J P Truant · Postgraduate Medical Journal · 1970 · 2.7K citations · Full text

, , +12

Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

Ana Espinel‐Ingroff · Journal of Clinical Microbiology · 1998 · 577 citations · Full text

, , +11

International Surveillance of Bloodstream Infections Due to <i>Candida</i> Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program

Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones et al. · Journal of Clinical Microbiology · 2001 · 523 citations · Full text

, , +15

Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of <i>Aspergillus</i> spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

Michael A. Pfaller, S. A. Messer, R. J. Hollis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 402 citations · Full text

, , +17